Cargando…
Profiling of immune features to predict immunotherapy efficacy
Immune checkpoint blockade (ICB) therapies exhibit substantial clinical benefit in different cancers, but relatively low response rates in the majority of patients highlight the need to understand mutual relationships among immune features. Here, we reveal overall positive correlations among immune...
Autores principales: | Ye, Youqiong, Zhang, Yongchang, Yang, Nong, Gao, Qian, Ding, Xinyu, Kuang, Xinwei, Bao, Rujuan, Zhang, Zhao, Sun, Chaoyang, Zhou, Bingying, Wang, Li, Hu, Qingsong, Lin, Chunru, Gao, Jianjun, Lou, Yanyan, Lin, Steven H., Diao, Lixia, Liu, Hong, Chen, Xiang, Mills, Gordon B., Han, Leng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8688727/ https://www.ncbi.nlm.nih.gov/pubmed/34977836 http://dx.doi.org/10.1016/j.xinn.2021.100194 |
Ejemplares similares
-
Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer
por: Zhang, Zhao, et al.
Publicado: (2019) -
Sex-associated molecular differences for cancer immunotherapy
por: Ye, Youqiong, et al.
Publicado: (2020) -
Multi-omics prediction of immune-related adverse events during checkpoint immunotherapy
por: Jing, Ying, et al.
Publicado: (2020) -
Characterization of the dual functional effects of heat shock proteins (HSPs) in cancer hallmarks to aid development of HSP inhibitors
por: Zhang, Zhao, et al.
Publicado: (2020) -
LncRNAs as tumor cell intrinsic factors that affect cancer immunotherapy
por: Egranov, Sergey D., et al.
Publicado: (2020)